SMTI: Sanara MedTech, Inc. Company Short-Term Debt

Symbol and logo of brand Sanara MedTech Inc. (SMTI)

This price chart for Sanara MedTech Inc. (SMTI) reflects the performance of a company developing advanced wound healing and surgical solutions. The business relies on the affordable manufacturing of proprietary bioactive elements, which ensures high margins. The current figure stands at 0.00. The enterprise's stability is supported by the growing implementation of innovations, which generates operating cash flow and protects working capital from depletion.

SMTI (sanaramedtech.com) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Metric breakdowns and analytics for Sanara MedTech, Inc. (SMTI)

- current quotes and average value forecast:
Price Chart Sanara|SMTI - Fair Value Consensus
- market capitalization information:
Market Value Sanara MedTech Inc.|SMTI - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Sanara MedTech|SMTI - Book Capitalization|Market Cap to Net Assets Ratio sanaramedtech.com|SMTI - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Sanara MedTech Inc.|SMTI - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Sanara|SMTI - Company Aggregate Debts|Debts to Book Capitalization Sanara MedTech Inc.|SMTI - Long-Term Debt Volume|Company Short-Term Debt Sanara MedTech|Quick Liquidity sanaramedtech.com
- net income and valuation multiples indicators:
SMTI - Net Financial Result
Analysis of all company metrics:sanaramedtech.com (SMTI)
Mass-produced product of Sanara

This indicator is calculated by summing all liabilities of Sanara MedTech Inc. (SMTI) due within twelve months. This metric determines the issuer's current debt load and solvency. For Sanara MedTech Inc. (SMTI), controlling these specified limits is critical when financing costly specialized pharmaceutical logistics for biologics. Analyzing the total amount of short-term debt allows for an assessment of liquidity shortage risks. The trend in total short-term debt reveals the company's resilience to volatility.

Competitors of Sanara MedTech Inc.

KRYS - Company Short-Term Debt|Company Short-Term Loans and Borrowings APGE (Apogee Therapeutics Inc)|Arcutis Biotherapeutics Inc (ARQT) - Company Short-Term Debt|Company Current Liabilities Vericel Inc.|ORKA (Oruka Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debts DBV Technologies SA|Company Current Liabilities SLSN (Solesence Inc)|DERM (journeymedicalcorp.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Forte Biosciences, Inc FBRX|Short-Term Debt Volume Empro Corporation (EMPG)|SLGL - Company Short-Term Debt|AXIL - Company Short-Term Debts|MDCX: Company Short-Term Debts|VRCA - Short-Term Debt Volume|Company Short-Term Debt Hoth Therapeutics Inc.|Company Short-Term Indebtedness BFRI (Biofrontera Inc)|Company Short-Term Debt VYNE Therapeutics (VYNE)|Short-Term Debt Volume sonomapharma.com|Company Short-Term Debts QNRX (Quoin Pharmaceuticals Ltd.)|Company Short-Term Debts Azitra Inc AZTR|DRMA - Company Short-Term Debt|ELAB (Elevai Corp) - Company Short-Term Indebtedness|RVNC: Company Short-Term Debts